Effect of superimposed infections on viral replication in human immunodeficiency virus type 1-infected children

Pediatric Infectious Disease Journal

Volumn 17, Issue 8, 1998, Pages 755-757

  Marchisio, Paola ^a   Esposito, Susanna ^a   Zanchetta, Nadia ^a   Tornaghi, Raffaella ^a   Gismondo, Maria Rita ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Human immunodeficiency virus infection; Viremia

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; STAVUDINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ACUTE PHASE RESPONSE; ADOLESCENT; ARTICLE; BACTERIAL PNEUMONIA; CHILD; CHRONICITY; CLINICAL ARTICLE; FEMALE; HELPER CELL; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MONONUCLEOSIS; OTITIS MEDIA; PRIORITY JOURNAL; SINUSITIS; SUPERINFECTION; TONSILLITIS; VIRUS GENE; VIRUS PNEUMONIA; VIRUS REPLICATION;

EID: 0031865711     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199808000-00020     Document Type: Article

References (15)

1. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
2. Balotta C, Colombo C, Colucci G, et al. Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J 1997;16:205-11.
3. + lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996;334:426-31.
4. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection:updated recommendations of the International AIDS Society-USA Panel. JAMA 1997;277: 1962-9.
5. Kovacs JA, Baseler M, Dewar RJ, et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection: a preliminary study. N Engl J Med 1995;332:567-75.
6. Stanley SK, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;334:1222-30.
7. Ramilo O, Hicks PJ, Borvak J, et al. T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. Pediatr Infect Dis J 1996; 15:197-203.
8. Donovan RM, Bush CE, Markowitz NP, Baxa DM, Saravolatz LD. Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected patients. J Infect Dis 1996;174:401-3.
9. Bush CE, Donovan RM, Markowitz NP, Kvale P, Saravolatz LD. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J Acquir Immune Defic Human Retrovir 1996;13:23-6.
10. Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995;16:187-91.
11. Galli L, De Martino M, Tovo PA, et al. Onset of clinical signs in children with HIV-1 perinatal infection. AIDS 1995;9:455-61.
12. Kaplan S, Mason E. Use of bacteriology, mycology and parasitology laboratories. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: Saunders, 1998:2857-73.
13. Miller M, Cherry JD. Use of diagnostic virology laboratory. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: Saunders, 1998:2873-92.
14. Mason EO. Use of serology laboratory. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: Saunders, 1998:2892-905.
15. CDC. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 1994; 43(RR-12):1-10.